Erratum to: Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc Min/+ mutation [BMC Genet., 17, (2016) (1)]. Doi: 10.1186/s12863-016-0349-6;Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc Min/+ mutation

BMC Genetics

Volumn 17, Issue 1, 2016, Pages

  Dorman, Alexandra ^a   Baer, Daria ^a   Tomlinson, Ian ^b   Mott, Richard ^b   Iraqi, Fuad A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Apc; Collaborative cross; Colorectal cancer; Familial adenomatous polyposis; Genetic modifier; Min +; Moms; Phenotyping; Recombinant Inbred lines

Indexed keywords

APC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APC GENE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CROSS BREEDING; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRAIT; HEMATOCRIT; HERITABILITY; INTESTINE LENGTH; INTESTINE POLYP; INTESTINE WEIGHT; MALE; MOUSE; NONHUMAN; NONSENSE MUTATION; ORGAN SIZE; ORGAN WEIGHT; PATHOGENESIS; PHENOTYPIC VARIATION; QUANTITATIVE TRAIT LOCUS MAPPING; SEX DIFFERENCE; SPLEEN WEIGHT; WILD TYPE; ANIMAL; C57BL MOUSE; COLON; COLON POLYPOSIS; DISEASE MODEL; GENETIC SCREENING; GENETICS; GENOTYPING TECHNIQUE; GERMLINE MUTATION; PATHOLOGY; PHENOTYPE; SMALL INTESTINE;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; BODY WEIGHT; COLON; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FEMALE; GENETIC LOCI; GENETIC TESTING; GENOTYPING TECHNIQUES; GERM-LINE MUTATION; INTESTINAL POLYPS; INTESTINE, SMALL; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; PHENOTYPE; SEX FACTORS;

EID: 84958544819     PISSN: None     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/s12863-016-0456-4     Document Type: Erratum

References (61)

1. Easton DF, Pooley KA, Dunning AM, Pharoah PDP, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447:1087-93.
2. Houlston RS, Cheadle J, Dobbins SE, Tenesa A, Jones AM, Howarth K, et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet. 2010;42:973-9.
3. McCarthy MI, Abecasis RG, Cardon LR, Goldstein DB, Little J, Ioannidis JPA, et al. Genome-wide association studies complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9:356-69.
4. Zanke BW, Greenwood CMT, Rangrej J, Kustra R, Tenesa A, Farrington SM, et al. Genome-wide scan indentifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet. 2007;39:989-94.
5. Barrett J, Jiwa M, Rose P, Hamilton W. Pathways to the diagnosis of colorectal cancer: an observational study in three UK cities. Fam Pract. 2005;14:9-15.
6. Auwera I, Laere SJ, Bosch SM, Eynden GG, Trinh BX, Dam PA, et al. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. Br J Cancer. 2008;99:1735-42.
7. Joslyn G, Carlson M, Thliveris A, Albertsen H, Gelbert L, Samowitz W, et al. Identification of deletion mutations and three new genes at the familial polyposis. Cell. 1991;66:601-13.
8. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet. 2001;10:721-33.
9. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991;66:589-600.
10. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253:661-5.
11. Fostira F, Thodi G, Sandaltzopoulos R, Fountzilas G, Yannoukakos D. Mutational spectrum of APC and genotype-phenotype correlations in Greek FAP patients. BMC Cancer. 2010;10:389-96.
12. Rubinfeld B, Souza B, Albert I. Association of the APC gene product with betacatenin. Science. 1993;262:1731-4.
13. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK-3β to the APC-β-catenin complex and regulation of complex assembly. Science. 1996;272:1023-6.
14. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science. 1997;275:1790-2.
15. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science. 1997;275:1787-90.
16. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 1999;18:5931-42.
17. Zhurinsky J, Shtutman M, Ben-Ze'ev A. Plakoglobin and b-catenin: protein interactions, regulation and biological roles. J Cell Sci. 2000;113:3127-39.
18. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 1998;58:1130-4.
19. Silverman KA, Koratkar RA, Siracusa LD, Buchberg AM. Exclusion of Madh2, Madh4, and Madh7 as candidates for the modifier of Min 2 (Mom2) locus. Mamm Genome. 2003;14:119-29.
20. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 2003;94:575-81.
21. Moser AR, Dove WF, Roth KA, Gordon JIL. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. Journal Cell Biology. 1992;716:1517-26.
22. Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN. Min, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci U S A. 1993;90:8977-81.
23. AKR resistance allele. Cancer Res. 2000;60:3965-70.
24. AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene. 2000;19:3182-92.
25. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell. 1993;75:631-9.
26. Cormier RT, Hong KH, Halberg RB, Hawkins TL, Richardson P. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet. 1997;17:88-91.
27. Silverman KA, Koratkar RA, Siracusa LD, Buchberg AM. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Genome Res. 2002;12:88-97.
28. Suraweera N, Haines J, McCart A, Rogers P, Latchford A, Coster M, et al. Genetic determinants modulate susceptibility to pregnancy-associated tumourigenesis in a recombinant line of Min mice. Hum Mol Genet. 2006;15:3429-35.
29. Nnadi SC, Watson R, Innocent J, Gonye GE, Buchberg AM, Siracusa LD. Identification of five novel modifier loci of Apc (Min) harbored in the BXH14 recombinant inbred strain. Carcinogenesis. 2012;33(8):1589-97.
30. Huang EH, Park JC, Appelman H, Weinberg AD, Banerjee M, Logsdom CD, et al. Induction of inflammatory bowel disease accelerates adenoma formation in Min+/- mice. Surgery. 2005;139:782-8.
31. Chesler EJ, Miller DM, Branstetter LR, Galloway LD, Jackson BL. The Collaborative Cross at Oak Ridge National Laboratory: developing a powerful resource for systems genetics. Mamm Genome. 2008;19:382-9.
32. Iraqi FA. Fine mapping of quantitative trait loci using advanced intercross lines of mice and positional cloning of the corresponding genes. Journal of Experimental Lung Research. 2000;26:641-9.
33. Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J, et al. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet. 2004;36:1133-7.
34. Iraqi FA, Churchill G, Mott R. The Collaborative Cross, developing a resource for mammalian systems genetics: A status report of the Wellcome Trust cohort. Mamm Genome. 2008;19:379-81.
35. Aylor DL, Valdar W, Foulds-Mathes W, Buus RJ, Verdugo RA, Baric RS, et al. Genetic analysis of complex traits in the emerging collaborative cross. Genome Res. 2011;21:1213-22.
36. Collaborative Cross Consortium. The Genome Architecture of the Collaborative Cross Mouse Genetic Reference Population. Genetics. 2012;190(2):389-402.
37. Durrant C, Tayem H, Yalcin B, Cleak J, Goodstadt L, de Villena PMF, et al. Collaborative Cross mice and their power to map host susceptibility to Aspergillus fumigates infection. Genome Res. 2011;21:1239-48.
38. Shusterman A, Salyma Y, Nashef A, Soller M, Wilensky A, Mott R, et al. Genotype is an important determinant factor of host susceptibility to periodontitis in the Collaborative Cross and inbred mouse populations. BMC Genet. 2013;14:68.
39. Iraqi FA, Athamni H, Dorman A, Salymah Y, Tomlinson I, Nashif A, et al. Heritability and coefficient of genetic variation analyses of phenotypic traits provide strong basis for high-resolution QTL mapping in the CollaborativeCross mouse genetic reference population. Mamm Genome. 2014;25:109-19.
40. Vered K, Durrant C, Mott R, Iraqi FA. Susceptibility to klebsiella pneumonaie infection in collaborative cross mice is a complex trait controlled by at least three loci acting at different time points. BMC Genomics. 2014;15:865.
41. Roberts A, Pardo-Manuel De Villena F, Wang W, McMillan L, Threadgill DW. The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics. Mamm Genome. 2007;18(6-7):473-81.
42. Beck JA, Lloyd S, Hafezparast M, Lennon-Pierce M, Eppig JT, Festing MFW, et al. Genealogies of mouse inbred strains. Nat Genet. 2000;24:23-5.
43. Keane TM, Goodstadt L, Danecek P, White MA, Wong K, Yalcin B, et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature. 2011;477(7364):289-94.
44. Wang M, Lemon WJ, Liu G, Wang Y, Iraqi FA, Malkinson AM, et al. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines. Cancer Research Journal. 2003;63:3317-24.
45. Broman KW. The genomes of recombinant inbred lines. Genetics. 2005;169(2):1133-46.
46. Yalcin B, Flint J, Mott R. Using Progenitor Strain Information to Identify Quantitative Trait Nucleotides in Outbreed Mice. Genetics. 2005;171:673-81.
47. Mathes WF, Aylor DL, Miller DR, Churchill GA, Chesler EJ, de Villena FP, et al. Architecture of energy balance traits in emerging lines of the Collaborative Cross. Am J Physiol. 2010;300:1124-34.
48. Welsh CE, Miller RD, Manly KF, Wang J, McMillan L, Morahan G, et al. Status and access to the Collaborative Cross population. Mamm Genome. 2012;23:706-12.
49. Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques. 2000;29(1):52-4.
50. min/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 2005;65:10623-31.
51. Rudling R, Hassan AB, Kitau J, Mandir N, Goodlad RA. A simple device to rapidly prepare whole mounts of murine intestine. Cell Prolif. 2006;39:415-20.
52. Janakiram NB, Mohammed A, Qian L, Choi CI, Steele VE, Rao CV. Chemopreventive Effects of RXR-Selective Rexinoid Bexarotene on Intestinal Neoplasia of ApcMin/+ Mice. Neoplasia. 2012;14:159-68.
53. Walker HK, Hall WD, Hurst JW. Clinical Methods: The History, Physical, and Laboratory Examinations 1990, 3rd edition.
54. Min/+ mice. J Appl Physiol. 2005;98(6):2219-25.
55. Min/+ mice. Am J Physiol. 2008;294:393-401.
56. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990;247:322-4.
57. Hinoi T, Akyol A, Theisen BK, Ferguson DO, Greenson JK, Williams BO, et al. Mouse Model of Colonic Adenoma-Carcinoma Progression Based on Somatic Apc Inactivation. Cancer Res. 2007;67:9721-30.
58. Qadri SM, Mahmud H, Lang E, Gu S, Bobbala D, Zelenak C, et al. Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J Cell Mol Med. 2012;16(5):1085-93.
59. Mori K, Fujimoto-Ouchi K, Onuma E, Noguchi M, Shimonaka Y, Yasuno H, et al. Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells. Biomed Res. 2000;30(1):47-51.
60. Lane SW, Sykes SM, Al-Shahrour F, Shterental S, Paktinat M, Lo Celso C, et al. The ApcMin mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS. Blood. 2010;115(17):3489-97.
61. Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR, Dove WF. ApcMin: A mouse model for intestinal and mammary tumorigenesis. Eur J Cancer. 1995;31:1061-4.